Southpoint Capital Advisors LP
•CIK: 1319998•Filing: Q4 2025
Southpoint Capital Advisors LP, managed by the seasoned duo of Keith Anderson and Jonathan Schildkraut, maintains a concentrated portfolio with $4.3 billion in assets under management, currently holding 38 positions. The fund has recently made notable shifts by adding Compugen and Teradyne significantly, while cutting Thermo Fisher Scientific by 70%, reflecting a strategic pivot towards growth-oriented tech and biotech sectors.
Total AUM
$4.3B
QoQ Performance
+12.8%
Positions
37
Top 10 Concentration
50.0%
Latest Filing
Q4 2025
Top Holdings Allocation
BDX
AMZN
MSFT
ILMN
AON
BDX6.3%
AMZN5.9%
MSFT5.6%
ILMN5.3%
AON5.3%
EXPD4.7%
Q4.6%
HSIC4.4%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other74.4%
Technology8.6%
Financial8.1%
Consumer7.5%
Healthcare1.3%
🚪 Exited Positionssold since Q3 2025
+12 more exited positions
Changes from Q3 2025
NEW14 new positions
↑8 increased
↓7 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023